331 related articles for article (PubMed ID: 25259750)
41. CD4⁺ but not CD8⁺ T cells revert the impaired emotional behavior of immunocompromised RAG-1-deficient mice.
Rattazzi L; Piras G; Ono M; Deacon R; Pariante CM; D'Acquisto F
Transl Psychiatry; 2013 Jul; 3(7):e280. PubMed ID: 23838891
[TBL] [Abstract][Full Text] [Related]
42. Activation of Human T Cells in Hypertension: Studies of Humanized Mice and Hypertensive Humans.
Itani HA; McMaster WG; Saleh MA; Nazarewicz RR; Mikolajczyk TP; Kaszuba AM; Konior A; Prejbisz A; Januszewicz A; Norlander AE; Chen W; Bonami RH; Marshall AF; Poffenberger G; Weyand CM; Madhur MS; Moore DJ; Harrison DG; Guzik TJ
Hypertension; 2016 Jul; 68(1):123-32. PubMed ID: 27217403
[TBL] [Abstract][Full Text] [Related]
43. Attenuated responses to angiotensin II in follitropin receptor knockout mice, a model of menopause-associated hypertension.
Javeshghani D; Touyz RM; Sairam MR; Virdis A; Neves MF; Schiffrin EL
Hypertension; 2003 Oct; 42(4):761-7. PubMed ID: 12885794
[TBL] [Abstract][Full Text] [Related]
44. Role of Axl in T-Lymphocyte Survival in Salt-Dependent Hypertension.
Batchu N; Hughson A; Wadosky KM; Morrell CN; Fowell DJ; Korshunov VA
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1638-1646. PubMed ID: 27365404
[TBL] [Abstract][Full Text] [Related]
45. Ikaros null mice display defects in T cell selection and CD4 versus CD8 lineage decisions.
Urban JA; Winandy S
J Immunol; 2004 Oct; 173(7):4470-8. PubMed ID: 15383578
[TBL] [Abstract][Full Text] [Related]
46. Evolution of responding CD4+ and CD8+ T-cell repertoires during the development of graft-versus-host disease directed to minor histocompatibility antigens.
Friedman TM; Jones SC; Statton D; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2004 Apr; 10(4):224-35. PubMed ID: 15077221
[TBL] [Abstract][Full Text] [Related]
47. Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats.
Novotny SR; Wallace K; Heath J; Moseley J; Dhillon P; Weimer A; Wallukat G; Herse F; Wenzel K; Martin JN; Dechend R; Lamarca B
Am J Physiol Regul Integr Comp Physiol; 2012 May; 302(10):R1197-201. PubMed ID: 22461177
[TBL] [Abstract][Full Text] [Related]
48. A novel role for type 1 angiotensin receptors on T lymphocytes to limit target organ damage in hypertension.
Zhang JD; Patel MB; Song YS; Griffiths R; Burchette J; Ruiz P; Sparks MA; Yan M; Howell DN; Gomez JA; Spurney RF; Coffman TM; Crowley SD
Circ Res; 2012 Jun; 110(12):1604-17. PubMed ID: 22534490
[TBL] [Abstract][Full Text] [Related]
49. Aldosterone-Induced Vascular Remodeling and Endothelial Dysfunction Require Functional Angiotensin Type 1a Receptors.
Briet M; Barhoumi T; Mian MOR; Coelho SC; Ouerd S; Rautureau Y; Coffman TM; Paradis P; Schiffrin EL
Hypertension; 2016 May; 67(5):897-905. PubMed ID: 27045029
[TBL] [Abstract][Full Text] [Related]
50. Immunization with an ApoB-100 Related Peptide Vaccine Attenuates Angiotensin-II Induced Hypertension and Renal Fibrosis in Mice.
Honjo T; Chyu KY; Dimayuga PC; Lio WM; Yano J; Trinidad P; Zhao X; Zhou J; Cercek B; Shah PK
PLoS One; 2015; 10(6):e0131731. PubMed ID: 26121471
[TBL] [Abstract][Full Text] [Related]
51. Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice.
Yang GX; Lian ZX; Chuang YH; Moritoki Y; Lan RY; Wakabayashi K; Ansari AA; Flavell RA; Ridgway WM; Coppel RL; Tsuneyama K; Mackay IR; Gershwin ME
Hepatology; 2008 Jun; 47(6):1974-82. PubMed ID: 18452147
[TBL] [Abstract][Full Text] [Related]
52. Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopause-associated hypertension.
Javeshghani D; Sairam MR; Neves MF; Schiffrin EL; Touyz RM
J Hypertens; 2006 Jul; 24(7):1365-73. PubMed ID: 16794486
[TBL] [Abstract][Full Text] [Related]
53. Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFβRII mice.
Kawata K; Yang GX; Ando Y; Tanaka H; Zhang W; Kobayashi Y; Tsuneyama K; Leung PS; Lian ZX; Ridgway WM; Ansari AA; He XS; Gershwin ME
Hepatology; 2013 Sep; 58(3):1094-104. PubMed ID: 23532950
[TBL] [Abstract][Full Text] [Related]
54. Reduced susceptibility to kainic acid-induced excitoxicity in T-cell deficient CD4/CD8(-/-) and middle-aged C57BL/6 mice.
Chen Z; Ljunggren HG; Zhu SW; Winblad B; Zhu J
J Neuroimmunol; 2004 Jan; 146(1-2):33-8. PubMed ID: 14698844
[TBL] [Abstract][Full Text] [Related]
55. Genetic and Pharmacologic Inhibition of the Chemokine Receptor CXCR2 Prevents Experimental Hypertension and Vascular Dysfunction.
Wang L; Zhao XC; Cui W; Ma YQ; Ren HL; Zhou X; Fassett J; Yang YZ; Chen Y; Xia YL; Du J; Li HH
Circulation; 2016 Nov; 134(18):1353-1368. PubMed ID: 27678262
[TBL] [Abstract][Full Text] [Related]
56. T lymphocytes and vascular inflammation contribute to stress-dependent hypertension.
Marvar PJ; Vinh A; Thabet S; Lob HE; Geem D; Ressler KJ; Harrison DG
Biol Psychiatry; 2012 May; 71(9):774-82. PubMed ID: 22361077
[TBL] [Abstract][Full Text] [Related]
57. Novel Role of T Cells and IL-6 (Interleukin-6) in Angiotensin II-Induced Microvascular Dysfunction.
Senchenkova EY; Russell J; Yildirim A; Granger DN; Gavins FNE
Hypertension; 2019 Apr; 73(4):829-838. PubMed ID: 30739537
[TBL] [Abstract][Full Text] [Related]
58. CD4+ and CD8+ T cells each can utilize a perforin-dependent pathway to mediate lethal graft-versus-host disease in major histocompatibility complex-disparate recipients.
Blazar BR; Taylor PA; Vallera DA
Transplantation; 1997 Aug; 64(4):571-6. PubMed ID: 9293867
[TBL] [Abstract][Full Text] [Related]
59. Caveolin-1 Deletion Prevents Hypertensive Vascular Remodeling Induced by Angiotensin II.
Forrester SJ; Elliott KJ; Kawai T; Obama T; Boyer MJ; Preston KJ; Yan Z; Eguchi S; Rizzo V
Hypertension; 2017 Jan; 69(1):79-86. PubMed ID: 27895190
[TBL] [Abstract][Full Text] [Related]
60. CD4-CD8-C.B-17 SCID thymocytes enter the CD4+CD8+ stage in the presence of neonatally grafted T cells.
Schneider MK; Grönvik KO
Scand J Immunol; 1998 May; 47(5):466-74. PubMed ID: 9627131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
